Isolation of group 1 and group 2 influenza A-neutralizing antibodies from H5N1 vaccinees
Discovery of three classes of broadly neutralizing antibodies directed to the HA stem
Delineation of sequence signatures specific for broadly neutralizing antibodies
Antibody quantification by NGS to guide the development of a universal vaccine